$2.690
+0.083 (+3.07%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Protalix Biotherapeutics Inc (PLX) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting PLX is Buy.
Protalix Biotherapeutics Inc (PLX) 20-Day simple moving average is 2.62, while Protalix Biotherapeutics Inc (PLX) share price is $—, making it Buy.
Protalix Biotherapeutics Inc (PLX) 60-Day simple moving average is 2.61, while Protalix Biotherapeutics Inc (PLX) share price is $—, making it Buy.
Technical Analysis for PLX
AI Technical PLXAs of 2026-11-03, the technical board for Protalix Biotherapeutics Inc (PLX) reads buy: 7 indicators are flashing buy, 2 are indicating sell, and 4 are neutral. Price at $2.69 sits above every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 55.342, MACD stands at -0.0149 (Sell), Stochastic %K stands at 56.218, Stochastic %D stands at 44.94 and CCI stands at 46.134.
PLX trades above the 60-day SMA (2.61) and above the 200-day SMA (2.42). Immediate resistance sits at Classic R1 2.72, then R2 2.86. Support sits at Classic S1 2.45, then S2 2.32.
Protalix Biotherapeutics Inc (PLX) Support & Resistance Level
Protalix Biotherapeutics Inc (PLX) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 55.342 |
| STOCHk_14_3_3 | 56.218 |
| STOCHd_14_3_3 | 44.940 |
| CCI_20 | 46.134 |
| AO_5_34 | -0.057 |
| MOM_10 | 0.120 |
| MACD_12_26_9 | -0.015 |
Protalix Biotherapeutics Inc (PLX) Relative Strength Index (RSI_14) is 55.342, creating a Neutral signal.
Protalix Biotherapeutics Inc (PLX) Stochastic %K is 56.218, creating a Neutral signal.
Protalix Biotherapeutics Inc (PLX) Stochastic %D is 44.940, creating a Neutral signal.
Protalix Biotherapeutics Inc (PLX) CCI_20 is 46.134, creating a Neutral signal.
Protalix Biotherapeutics Inc (PLX) Awesome Oscillator (AO) is -0.057, creating a Sell signal.
Protalix Biotherapeutics Inc (PLX) Momentum (MOM) is 0.120, creating a Buy signal.
Protalix Biotherapeutics Inc (PLX) Moving Average Convergence Divergence (MACD) is -0.015, creating a Sell signal.
Protalix Biotherapeutics Inc (PLX) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 2.612 | Buy |
| MA_10 | 2.578 | Buy |
| MA_20 | 2.624 | Buy |
| MA_60 | 2.611 | Buy |
| MA_200 | 2.422 | Buy |
| MA_250 | 2.310 | Buy |
Protalix Biotherapeutics Inc (PLX) 5-Day simple moving average is 2.612, while Protalix Biotherapeutics Inc (PLX) share price is $, making it a Buy.
Protalix Biotherapeutics Inc (PLX) 10-Day simple moving average is 2.578, while Protalix Biotherapeutics Inc (PLX) share price is $, making it a Buy.
Protalix Biotherapeutics Inc (PLX) 20-Day simple moving average is 2.624, while Protalix Biotherapeutics Inc (PLX) share price is $, making it a Buy.
Protalix Biotherapeutics Inc (PLX) 60-Day simple moving average is 2.611, while Protalix Biotherapeutics Inc (PLX) share price is $, making it a Buy.
Protalix Biotherapeutics Inc (PLX) 200-Day simple moving average is 2.422, while Protalix Biotherapeutics Inc (PLX) share price is $, making it a Buy.
Protalix Biotherapeutics Inc (PLX) 250-Day simple moving average is 2.310, while Protalix Biotherapeutics Inc (PLX) share price is $, making it a Buy.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.